Analyst Ratings for Ironwood Pharmaceuticals (IRWD) [Buys]
IRWD Rating Summary
IRWD Price Target Summary
- Highest: $24.00 (Credit Suisse)
- Lowest: $8.00 (Cantor Fitzgerald)
- Average: $15.30
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$15.30 (+23.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/15/2013 | Credit Suisse | Upgrade | Outperform (Neutral) |
24.00 (15.00) |
17.68 | 12.43 | -29.69% | Details |
| 11/9/2012 | Mizuho Securities | New Coverage | Outperform (N/A) |
22.00 (N/A) |
11.68 | 12.43 | 6.42% | Details |
| 6/12/2012 | Aegis Capital | New Coverage | Buy (N/A) |
17.00 (N/A) |
12.41 | 12.43 | 0.16% | Details |
| 8/26/2011 | Morgan Joseph | New Coverage | Buy (N/A) |
20.00 (N/A) |
12.26 | 12.43 | 1.39% | Details |
| 5/5/2011 | Caris & Co. | New Coverage | Buy (N/A) |
N/A (N/A) |
14.10 | 12.43 | -11.84% | Details |
| 9/8/2010 | Ladenburg Thalmann | New Coverage | Buy (N/A) |
N/A (N/A) |
9.27 | 12.43 | 34.09% | Details |
